{
  "id": 3758823,
  "title": "Early trials for 'common cold' vaccine offer encouraging signs",
  "url": "https://urgent.news/2026/08/27/early-trials-for-common-cold-vaccine-offer-encouraging-signs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T14:40:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-early-trials-common-cold-vaccine.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a phase 1 clinical trial. Initial findings from the study showed that the vaccine candidate (APL-10456) was well tolerated in healthy volunteers and induced immunity against multiple rhinovirus species.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}